Centrepoint Alliance Limited (CAF.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 04:10PM AEST
| Previous close | 0.2900 |
| Open | 0.3000 |
| Bid | 0.2950 x 11700000 |
| Ask | 0.3050 x 350200 |
| Day's range | 0.2950 - 0.3050 |
| 52-week range | 0.2050 - 0.3500 |
| Volume | |
| Avg. volume | 52,235 |
| Market cap | 60.659M |
| Beta (5Y monthly) | 1.02 |
| PE ratio (TTM) | 7.63 |
| EPS (TTM) | 0.0400 |
| Earnings date | 26 Feb 2024 |
| Forward dividend & yield | 0.02 (6.56%) |
| Ex-dividend date | 01 Mar 2024 |
| 1y target est | N/A |
GlobeNewswireBionomics Announces Key Leadership Updates to Drive U.S.-Focused Transformation and Next Stage of Strategic Growth
Alan Fisher appointed Chair of the Board of DirectorsTim Cunningham joins as Chief Financial Officer ADELAIDE, Australia and CAMBRIDGE, Mass., July 03, 2023 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to treat patients suffering from serious central nervous system (CNS) disorders with high unmet medical need, today announced key leadership updates
© 2024 Yahoo. All rights reserved.